Cancer prevention and treatment for people living with HIV through coordinated trials
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535256 · Data updated 2026-11-12
A large, ongoing program tests new cancer treatments and prevention strategies specifically for people living with HIV to reduce cancer burden.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $611,696 |
| NIH project number | 3UM1CA121947-20S8 |
| Project ID | NIH-11535256 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults living with HIV who are at risk for or currently have AIDS-related cancers and are eligible for participating clinical trials.
✕Less likely to help
Patients not eligible for specific trials or with cancers not covered by AMC's current portfolio may not directly benefit.
What this research studies
The AIDS Malignancy Consortium coordinates multi-site clinical trials to explore new therapies and prevention efforts for cancers that commonly affect people with HIV, with the goal of improving survival and quality of life. It builds collaboration between researchers, clinicians, and patient advocates to study cancer biology and how best to prevent and treat these cancers in diverse populations. The program includes a network of trial sites, translational science, and career development to sustain leadership in AIDS-related cancer care.
Why it matters
Potential benefit: If successful, the program could lead to better cancer prevention, faster access to effective treatments, and improved guidelines for people with HIV.
How similar studies have gone: AMC has conducted numerous interventional trials leading to guideline-informing evidence and practice changes.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.